US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist

1.5200
+0.0200+1.33%

Close Nov 29 13:00 ET

1.5200
0.00000.00%

Post 17:01 ET

114.00MMarket Cap-1727P/E (TTM)

Context Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

202.59%18.7M

-41.64%3.09M

-42.65%3.82M

68.49%25.07M

78.58%6.93M

52.68%6.18M

50.87%5.29M

93.63%6.67M

100.07%14.88M

25.56%3.88M

Selling and administrative expenses

10.67%1.88M

-6.96%1.7M

-13.21%1.85M

-6.42%7.29M

-6.11%1.63M

-13.97%1.7M

-7.99%1.83M

1.93%2.13M

114.43%7.79M

-3.38%1.74M

-General and administrative expense

10.67%1.88M

-6.96%1.7M

-13.21%1.85M

-6.42%7.29M

-6.11%1.63M

-13.97%1.7M

-7.99%1.83M

1.93%2.13M

114.43%7.79M

-3.38%1.74M

Research and development costs

275.13%16.83M

-59.99%1.38M

-56.49%1.97M

150.77%17.78M

147.19%5.3M

115.89%4.49M

128.11%3.46M

235.53%4.53M

86.36%7.09M

65.80%2.14M

Operating profit

-202.59%-18.7M

41.64%-3.09M

42.65%-3.82M

-68.49%-25.07M

-78.58%-6.93M

-52.68%-6.18M

-50.87%-5.29M

-93.63%-6.67M

-100.07%-14.88M

-25.56%-3.88M

Net non-operating interest income expense

328.21%1.24M

186.47%840.15K

-57.15%152.35K

112.69%1.16M

-31.46%224.72K

51.08%290.44K

1,277.13%293.27K

5,963.13%355.54K

951.91%547.27K

103,983.49%327.86K

Non-operating interest income

328.21%1.24M

186.47%840.15K

-57.15%152.35K

112.69%1.16M

-31.46%224.72K

51.08%290.44K

1,277.13%293.27K

5,963.13%355.54K

--547.27K

--327.86K

Other net income (expense)

-114.00%-2.15K

50.05%-6.11K

24.74%3.35K

88.93%-55.57K

-2,568.41%-61.4K

903.20%15.37K

97.55%-12.23K

316.95%2.69K

83.01%-502K

-733.70%-2.3K

Special income (charges)

----

--0

----

83.81%-500K

--0

-Less:Other special charges

----

-83.81%500K

--0

Other non- operating income (expenses)

-114.00%-2.15K

50.05%-6.11K

24.74%3.35K

-2,672.95%-55.57K

-2,568.41%-61.4K

903.20%15.37K

-305,775.00%-12.23K

316.95%2.69K

-101.62%-2K

-733.70%-2.3K

Income before tax

-197.21%-17.46M

55.01%-2.25M

41.86%-3.67M

-61.53%-23.96M

-90.34%-6.77M

-52.42%-5.87M

-25.71%-5.01M

-83.47%-6.31M

-41.88%-14.84M

-15.04%-3.56M

Income tax

Net income

-197.21%-17.46M

55.01%-2.25M

41.86%-3.67M

-61.53%-23.96M

-90.34%-6.77M

-52.42%-5.87M

-25.71%-5.01M

-83.47%-6.31M

-41.88%-14.84M

-15.04%-3.56M

Net income continuous Operations

-197.21%-17.46M

55.01%-2.25M

41.86%-3.67M

-61.53%-23.96M

-90.34%-6.77M

-52.42%-5.87M

-25.71%-5.01M

-83.47%-6.31M

-41.88%-14.84M

-15.04%-3.56M

Minority interest income

Net income attributable to the parent company

-197.21%-17.46M

55.01%-2.25M

41.86%-3.67M

-61.53%-23.96M

-90.34%-6.77M

-52.42%-5.87M

-25.71%-5.01M

-83.47%-6.31M

-41.88%-14.84M

-15.04%-3.56M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-197.21%-17.46M

55.01%-2.25M

41.86%-3.67M

-61.53%-23.96M

-90.34%-6.77M

-52.42%-5.87M

-25.71%-5.01M

-83.47%-6.31M

-41.88%-14.84M

-15.04%-3.56M

Basic earnings per share

40.54%-0.22

87.10%-0.04

42.50%-0.23

-61.29%-1.5

-90.91%-0.42

-54.17%-0.37

-24.00%-0.31

-81.82%-0.4

74.80%-0.93

-13.61%-0.22

Diluted earnings per share

40.54%-0.22

87.10%-0.04

42.50%-0.23

-61.29%-1.5

-90.91%-0.42

-54.17%-0.37

-24.00%-0.31

-81.82%-0.4

74.80%-0.93

-13.61%-0.22

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	202.59%18.7M	-41.64%3.09M	-42.65%3.82M	68.49%25.07M	78.58%6.93M	52.68%6.18M	50.87%5.29M	93.63%6.67M	100.07%14.88M	25.56%3.88M
Selling and administrative expenses	10.67%1.88M	-6.96%1.7M	-13.21%1.85M	-6.42%7.29M	-6.11%1.63M	-13.97%1.7M	-7.99%1.83M	1.93%2.13M	114.43%7.79M	-3.38%1.74M
-General and administrative expense	10.67%1.88M	-6.96%1.7M	-13.21%1.85M	-6.42%7.29M	-6.11%1.63M	-13.97%1.7M	-7.99%1.83M	1.93%2.13M	114.43%7.79M	-3.38%1.74M
Research and development costs	275.13%16.83M	-59.99%1.38M	-56.49%1.97M	150.77%17.78M	147.19%5.3M	115.89%4.49M	128.11%3.46M	235.53%4.53M	86.36%7.09M	65.80%2.14M
Operating profit	-202.59%-18.7M	41.64%-3.09M	42.65%-3.82M	-68.49%-25.07M	-78.58%-6.93M	-52.68%-6.18M	-50.87%-5.29M	-93.63%-6.67M	-100.07%-14.88M	-25.56%-3.88M
Net non-operating interest income expense	328.21%1.24M	186.47%840.15K	-57.15%152.35K	112.69%1.16M	-31.46%224.72K	51.08%290.44K	1,277.13%293.27K	5,963.13%355.54K	951.91%547.27K	103,983.49%327.86K
Non-operating interest income	328.21%1.24M	186.47%840.15K	-57.15%152.35K	112.69%1.16M	-31.46%224.72K	51.08%290.44K	1,277.13%293.27K	5,963.13%355.54K	--547.27K	--327.86K
Other net income (expense)	-114.00%-2.15K	50.05%-6.11K	24.74%3.35K	88.93%-55.57K	-2,568.41%-61.4K	903.20%15.37K	97.55%-12.23K	316.95%2.69K	83.01%-502K	-733.70%-2.3K
Special income (charges)	----	----	----	--0	----	----	----	----	83.81%-500K	--0
-Less:Other special charges	----	----	----	----	----	----	----	----	-83.81%500K	--0
Other non- operating income (expenses)	-114.00%-2.15K	50.05%-6.11K	24.74%3.35K	-2,672.95%-55.57K	-2,568.41%-61.4K	903.20%15.37K	-305,775.00%-12.23K	316.95%2.69K	-101.62%-2K	-733.70%-2.3K
Income before tax	-197.21%-17.46M	55.01%-2.25M	41.86%-3.67M	-61.53%-23.96M	-90.34%-6.77M	-52.42%-5.87M	-25.71%-5.01M	-83.47%-6.31M	-41.88%-14.84M	-15.04%-3.56M
Income tax
Net income	-197.21%-17.46M	55.01%-2.25M	41.86%-3.67M	-61.53%-23.96M	-90.34%-6.77M	-52.42%-5.87M	-25.71%-5.01M	-83.47%-6.31M	-41.88%-14.84M	-15.04%-3.56M
Net income continuous Operations	-197.21%-17.46M	55.01%-2.25M	41.86%-3.67M	-61.53%-23.96M	-90.34%-6.77M	-52.42%-5.87M	-25.71%-5.01M	-83.47%-6.31M	-41.88%-14.84M	-15.04%-3.56M
Minority interest income
Net income attributable to the parent company	-197.21%-17.46M	55.01%-2.25M	41.86%-3.67M	-61.53%-23.96M	-90.34%-6.77M	-52.42%-5.87M	-25.71%-5.01M	-83.47%-6.31M	-41.88%-14.84M	-15.04%-3.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-197.21%-17.46M	55.01%-2.25M	41.86%-3.67M	-61.53%-23.96M	-90.34%-6.77M	-52.42%-5.87M	-25.71%-5.01M	-83.47%-6.31M	-41.88%-14.84M	-15.04%-3.56M
Basic earnings per share	40.54%-0.22	87.10%-0.04	42.50%-0.23	-61.29%-1.5	-90.91%-0.42	-54.17%-0.37	-24.00%-0.31	-81.82%-0.4	74.80%-0.93	-13.61%-0.22
Diluted earnings per share	40.54%-0.22	87.10%-0.04	42.50%-0.23	-61.29%-1.5	-90.91%-0.42	-54.17%-0.37	-24.00%-0.31	-81.82%-0.4	74.80%-0.93	-13.61%-0.22
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data